dihexa molecular formula | 1401708-83-5 | BGC70883 Dihexa 10 mg for Laboratory

A special committee investigation by the relevant institutions found that Leen Kawas (first author on Benoist 2014, co-author on McCoy 2013, and at the time CEO of the biotech commercializing a Dihexa derivative) had altered images in her doctoral dissertation and at least four published research papers from the Harding laboratory between approximately 2008 and 2012

Manage weight or body composition shifts: Ask your healthcare professional about proven treatments like GLP-1s, berberine, or targeted nutrition and lifestyle strategies

Industry Response: The compounding pharmacy industry, medical practitioners, and patient advocacy groups pushed back against the Category 2 classification, arguing that the safety data did not support such a restrictive designation

For companies engaged in compounding of GLP-1 drug products, the warnings signal a need to reassess labeling, advertising, and promotional strategies